NewGenIvf Group Limited is a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments. The Company offers services, such as Mitochondrial Replacement Therapy In Reproductive, Intrauterine Insemination (IUI), Mitochondrial replacement therapy (MRT) techniques, In Vitro Fertilization (IVF) and Intracytoplasmic Sperm Injection (ICSI), semen analysis, testicular / epididymal sperm aspiration or extraction / percutaneous epididymal sperm aspiration, embryo transfer, chromosome screening and egg freezing. The Company’s clinics are located in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions. MRT involves an additional egg from a third person, and manipulating both the recipient egg and the donor egg.
종목 코드 NIVFW
회사 이름NewGenIvf Group Ltd
상장일Feb 15, 2022
CEOMr. Claudius Tsang
직원 수- -
유형Company Warrant
회계 연도 종료- -
주소Level 39, Marina Bay Financial Centre
도시
증권 거래소NASDAQ Capital Market Consolidated
국가Singapore
우편 번호018983
전화6568185796
웹사이트https://newgenivf.com/
종목 코드 NIVFW
상장일Feb 15, 2022
CEOMr. Claudius Tsang
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음